Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$172K Buy
1,800
+300
+20% +$27.1K ﹤0.01% 5345
2014
Q2
$137K Sell
1,500
-2,300
-61% -$206K ﹤0.01% 5578
2014
Q1
$334K Sell
3,800
-5,100
-57% -$448K ﹤0.01% 4654
2013
Q4
$826K Buy
8,900
+5,800
+187% +$522K ﹤0.01% 3751
2013
Q3
$253K Sell
3,100
-2,500
-45% -$211K ﹤0.01% 4885
2013
Q2
$466K Buy
+5,600
New +$482K ﹤0.01% 4172

Other funds holding CLX

UBS's CLX Position: Q3 2014 in Review

UBS reduced its Clorox (CLX) stake by 9.1% in Q3 2014, selling an estimated $9.96M and leaving 1,098,136 shares worth $105M. The position accounts for 0.08% of the portfolio, ranked #255.

UBS first reported a position in CLX in Q2 2013 and has held it in 6 quarters since. The position peaked at $277M in Q4 2013. 676 funds tracked by Wall St. Rank hold CLX as of Q3 2014.

  • UBS held 1,098,136 shares of Clorox worth $105M as of Q3 2014.
  • UBS sold 110,171 Clorox shares in Q3 2014, an estimated $9.96M.
  • Clorox made up 0.08% of UBS's portfolio in Q3 2014, its #255 holding.
  • UBS first reported a position in Clorox in Q2 2013 and has held it in 6 quarters since.
  • UBS's Clorox position peaked at $277M in Q4 2013.
  • 676 funds tracked by Wall St. Rank held Clorox as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.